Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)

Antiresorptive therapy is the main form of prevention of osteoporotic or fragility fractures. Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but severe adverse reaction to antiresorptive and antiangiogenic drugs. Physicians and dentists caring for patients taking these drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeira, Miguel, Rocha, André Caroli, Moreira, Carolina Aguiar, Aguiar, Águida Maria Menezes, Maeda, Sergio Setsuo, Cardoso, Abel Silveira, Castro, Charlles Heldan de Moura, D'Alva, Catarina Brasil, Silva, Barbara Campolina Carvalho, Ferraz-de-Souza, Bruno, Lazaretti-Castro, Marise, Bandeira, Francisco, Torres, Sandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528626/
https://www.ncbi.nlm.nih.gov/pubmed/34033275
http://dx.doi.org/10.20945/2359-3997000000301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528626/
https://www.ncbi.nlm.nih.gov/pubmed/34033275
http://dx.doi.org/10.20945/2359-3997000000301

Ejemplares similares